Vertex Pharmaceuticals
NEWS
Female leaders in the biopharma industry may further promote diversity and inclusion at the workplace and serve as role models for young female professionals. Here is a list of 16 of the highest-paid female CEOs in biopharma.
Vertex Pharmaceuticals announced that after early data on its Phase II trial of VX-814 in Alpha-1 antitrypsin deficiency (AATD), it is halting the trial and ending development of the drug.
It was a busy week for clinical trial updates. Here’s a look.
Based on the positive results of Trikafta, the company plans to submit sNDA to the FDA in the fourth quarter and other regulatory agencies around the world afterward.
Biopharma and life sciences companies bolster their leadership teams and board with these Movers & Shakers.
It was a fairly busy week with clinical trial updates and announcements. Here’s a look.
Although some clinical trials are being slowed or halted, others are reporting out data. Here’s a look.
The $500,000 gift was in response to the COVID-19 outbreak and a need for more support, testing capacity and advancements.
The U.S. Food and Drug Administration has two PDUFA dates this week, one for a type of epilepsy and the other for a triple-combination drug for cystic fibrosis. Here’s a look.
JOBS
IN THE PRESS